Sandoz, Inc. Recalls One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL


Pharmaceutical Recall Related Images

nanomaterials discovery corporation snowy range blue alcohol antiseptic
medical recall
quinapril and hydrochlorothiazide tablets
Product Image Not Available
Product Image Not Available

Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a recall of one lot (SAB06761A, Exp 04/2023) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL Single-Dose Syringes to the consumer level. A portion of lot SAB06761A experienced a temperature excursion during shipment. Enoxaparin Sodium for Injection Lot SAB06761A was shipped to customers in the months of September and October 2021.

The exposure to higher temperatures may have significantly impacted the recalled product’s (lot SAB06761A) effectiveness and thus there may be reasonable probability of risk for patients with health conditions that the product is intended to treat. Such patients could be at risk for blood clots blocking blood vessels, an artery, or traveling to other tissues or organs causing pain, swelling, stroke, clots to the lung or death as a result of the underlying condition. To date, Sandoz has not received any reports of adverse events or injuries related to this recall.

The product is used for prevention of deep vein thrombosis (DVT) a condition that occurs when a blood clot forms in a deep vein, usually in the legs that can occur after surgeries or in patients with restricted mobility during illness; or prevention of complications associated with heart attacks. The product is packaged in cartons containing ten 0.4 mL syringes, NDC 0781-3246-64. Enoxaparin Sodium Injection was distributed Nationwide in the USA to wholesalers and retailers.

Product NameNDC NumberLot
Number
Expiration
Date
Date of
Manufacture
Enoxaparin Sodium
Injection, USP 40
mg/0.4 mL
00781-3246-64SAB06761A04/202305/26/2021

Please note: this recall is specific to only one batch (SAB06761A) of Enoxaparin Sodium Injection, USP 40 mg/0.4 mL and does not apply to any other strengths of Sandoz Enoxaparin Sodium Injection, USP or to other lots of the 40 mg/0.4 mL SKU.

Any product returned that is not associated with this recall will be destroyed and no credit issued.

Sandoz has already notified its wholesalers and retailers by mail and is arranging for return of all recalled product.

Consumers who have Enoxaparin Sodium Injection, USP 40 mg/0.4 mL (NDC 00781-3246-64 and Lot number SAB06761A) which is being recalled, should stop taking the recalled product, immediately consult with their physician to attain another prescription, and return the product where originally purchased. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Pharmacists should contact Sedgwick directly by phone at 844-265-7389 or by email at sandoz4623@sedgwick.com to request a recall packet. Representatives are available Monday – Friday, 8:00 am – 5:00 pm ET.

In case of any adverse reactions, please call Sandoz at (800) 525-8747 or email qa.drugsafety@sandoz.com. Customer service agents are available Monday – Friday from 8:30 am to 5:00 pm ET. Adverse events can also be reported to FDA online at www.fda.gov/medwatch/report.htm.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

*Enoxaparin sodium injection is a product of Sandoz, Inc.

Original recall and updates at FDA


Related Posts

aurobindo pharma usa acetaminophen aspirin and caffeine tablets label
Aurobindo Pharma USA, Inc. Recalls AuroHealth Healthy Living Over the Counter Migraine Relief Acetaminophen/Caffeine Tablets
Aurobindo Pharma USA, Inc. Recalls AuroHealth Healthy Living Over the Counter Migraine Relief Acetaminophen/Caffeine Tablets
clonazepam orally disintegrating tablets
Endo USA, Inc. Recalls Lot 550147301 of Clonazepam Orally Disintegrating Tablets
Endo USA, Inc. Recalls Lot 550147301 of Clonazepam Orally Disintegrating Tablets
volara system
Baxter Issues Urgent Medical Device Recall for Volar System Single-Patient Use Circuit
Baxter Issues Urgent Medical Device Recall for Volar System Single-Patient Use Circuit
umary acido hialuronica
SoloVital Recalls Umary Acido Hialuronica, Suplemento Alimenticio 850 mg Capsules
SoloVital Recalls Umary Acido Hialuronica, Suplemento Alimenticio 850 mg Capsules

Latest Posts

aldi logo
ALDI Recalls Jalapenos, Green Peppers and Green Beans Due to Potential Listeria Contamination
snowfruit logo
JFE Franchising, Inc. Recalls Variety of Products Because Of Possible Listeria
wiers farm cucumber bags and labels
Wiers Farm, Inc Expands Recall on Whole and Salad Cucumbers Due to Possible Listeria
hover 1 dynamo e scooter
DGL Group Recalls Hover-1 Dynamo E-Scooters Sold Exclusively at Walmart
artic cat mountain 600 snowmobile
Textron Specialized Vehicles Recalls 2024 Arctic Cat Mountain 600 Snowmobiles

Leave a Reply

Your email address will not be published. Required fields are marked *

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.